Breast Cancer

, Volume 9, Issue 3, pp 216–219 | Cite as

P63 expression in normal, hyperplastic and malignant breast tissues

  • Xiaojuan Wang
  • Ichiro Mori
  • Weihua Tang
  • Misa Nakamura
  • Yasushi Nakamura
  • Misako Sato
  • Takeo Sakurai
  • Kennichi Kakudo
Original Article

Abstract

Background

p63 is a homologue of the p53 tumor suppressor gene and its protein is selectively expressed in the basal cells of a variety of epithelial tissues. It has recently been confirmed that p63 is expressed in the basal cells of normal prostate glands but not in prostatic carcinomas. Whether expression of p63 in breast correlates with tumor progression is the focus of this study.

Methods

Forty cases, which all contained normal breast tissue, ductal hyperplasia, ductal carcinomain situ and invasive ductal carcinoma in the same patient were included in this investigation using an indirect immunohistochemical method and double staining.

Results

p63 was exclusively expressed in the myoepithelial cells of normal breast, partially expressed in ductal hyperplasia, rarely expressed in carcinomain situ and not expressed in invasive carcinomas.

Conclusions

The results suggest an association between loss of p63 expression and progression of breast ductal carcinoma. p63 immunostaining might be of assistance for distinguishing invasive ductal carcinoma from ductal carcinomain situ or rare questionable ductal hyperplastic lesions, leading to correct therapy clinically.

Key words

p63 Ductal intraepithelial neoplasia Intraductal hyperplasia Atypical ductal hyperplasia Ductal carcinomain situ Breast cancer Immunohistochemistry 

Abbreviations

DCIS

Ductal carcinomain situ

SMA

Smooth muscle actin

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Yang A, Kaghad M, Wang Y,et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.Mol Cell 2: 305–316, 1998.PubMedCrossRefGoogle Scholar
  2. 2).
    Parsa R, Yang A, McKeon F,et al: Association of p63 with proliferative potential in normal and neoplastic human keratinocytes.J Invest Dermatol 113: 1099–1105, 1999.PubMedCrossRefGoogle Scholar
  3. 3).
    Signoretti S, Waltregny D, Dilks J,et al: p63 is a prostate basal cell marker and is required for prostate development.Am J Pathol 157: 1769–1775, 2000.PubMedGoogle Scholar
  4. 4).
    Tavassoli FA: Ductal intraepithelial neoplasia (IDH, AIDH and DCIS).Breast Cancer 7: 315–320, 2000.PubMedCrossRefGoogle Scholar
  5. 5).
    Trink B, Okami K, Wu L,et al: A new human p53 homologue.Nat Med 248: 603–607, 1998.Google Scholar
  6. 6).
    Strano S, Rossi M, Fontemaggi G,et al: From p63 to p53 across p73.FEBS Lett 16: 163–170, 2001.CrossRefGoogle Scholar
  7. 7).
    Yang A, Schweitzer R, Sun D,et al: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.Nature 398: 714–718, 1999.PubMedCrossRefGoogle Scholar
  8. 8).
    Mills AA, Zheng B, Wang XJ,et al: p63 is p53 homologue required for limb and epidermal morphogenesis.Nature 398: 708–713, 1999.PubMedCrossRefGoogle Scholar
  9. 9).
    Gaiddon C, Lokshin M, Ahn J,et al: A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.Mol Cell Biol 21: 1874–1887, 2001.PubMedCrossRefGoogle Scholar
  10. 10).
    De Laurenzi V, Melilno G: Evolution of functions within the p53/p63/p73 family.Ann N Y Sci 926: 90–100, 2000.CrossRefGoogle Scholar
  11. 11).
    Osborne MP: Breast anatomy and development. In: Harris, Jay R eds, Diseases of the Breast, 2nd ed, Lippincott Williams & Wilkins, Philadelphia, p9, 2000.Google Scholar
  12. 12).
    Barbareschi M, Pecciarini L, Cangi MG,et al: p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.Am J Surg Pathol 25: 1054–1060, 2001.PubMedCrossRefGoogle Scholar
  13. 13).
    Kaelin WGJ: The emerging p53 gene family.J Natl Cancer Inst 91: 594–594, 1999.PubMedCrossRefGoogle Scholar
  14. 14).
    Yang A, McKeon F, Wang Y,et al: p63 and p73: p53 mimics, menaces and more.Nature Rev Mol Cell Biol 1: 194–207, 2000.Google Scholar
  15. 15).
    Gottlieb C, Raju U, Greenwald KA: Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an Immunohistochemical study.Mod Pathol 3: 134–140, 1990.Google Scholar
  16. 16).
    Xiaojuan W, Ichiro M, Weihua T,et al: Metaplastic carcinoma of the Breast: p53 analysis identified the same point mutation in the three histologic components.Mod Pathol 14: 1183–1186, 2001.CrossRefGoogle Scholar
  17. 17).
    Glickman JN, Yang A, Shahsafaei A,et al: Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.Hum Pathol 32: 1157–1165, 2001.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2002

Authors and Affiliations

  • Xiaojuan Wang
    • 1
  • Ichiro Mori
    • 1
  • Weihua Tang
    • 1
  • Misa Nakamura
    • 1
  • Yasushi Nakamura
    • 1
  • Misako Sato
    • 1
  • Takeo Sakurai
    • 2
  • Kennichi Kakudo
    • 1
  1. 1.Department of PathologyWakayama Medical UniversityJapan
  2. 2.Department of Surgery, Kihoku Affiliated HospitalWakayama Medical UniversityJapan

Personalised recommendations